“The Little Pink Pill”
This month, Flibanserin, commonly referred to as “female Viagra,” goes to the full Food and Drug Administration for a vote of approval. In early June, a federal advisory committee to the FDA recommended approval. The final vote is due on or before August 18. The entire concept of Female Sexual Dysfunction (FSD) is controversial. Does … Read more
